Corletto Daniela, Iori Mauro, Paiusco Marta, Brait Lorenzo, Broggi Sara, Ceresoli Giovanni, Iotti Cinzia, Calandrino Riccardo, Fiorino Claudio
Servizio di Fisica Sanitaria, H San Raffaele, Via Olgettina 60, 20132 Milan, Italy.
Radiother Oncol. 2003 Feb;66(2):185-95. doi: 10.1016/s0167-8140(02)00375-4.
Intensity-modulated radiation therapy (IMRT) was suggested as a suitable technique to protect the rectal wall, while maintaining a satisfactory planning target volume (PTV) irradiation in the case of high-dose radiotherapy of prostate cancer. However, up to now, few investigations tried to estimate the expected benefit with respect to conventional three-dimensional (3D) conformal radiotherapy (CRT).
Estimating the expected clinical gain coming from both 1D and 2D IMRT against 3DCRT, in the case of prostate cancer by mean of radiobiological models. In order to enhance the impact of IMRT, the case of concave-shaped PTV including prostate and seminal vesicles (P+SV) was considered.
Five patients with concave-shaped PTV including P+SV were selected. Two different sets of constraints were applied during planning: in the first one a quite large inhomogeneity of the dose distribution within the PTV was accepted (set (a)); in the other set (set (b)) a greater homogeneity was required. Tumor control probability (TCP) and normal tissue control probability (NTCP) indices were calculated through the Webb-Nahum and the Lyman-Kutcher models, respectively. Considering a dose interval from 64.8 to 100.8 Gy, the value giving a 5% NTCP for the rectum was found (D(NTCP(rectum)=5%)) using two different methods, and the corresponding TCP(NTCP(rectum)=5%) and NTCP(NTCP(rectum)=5%) for the other critical structures were derived. With the first method, the inverse optimization of the plans was performed just at a fixed 75.6 Gy ICRU dose; with the second method (applied to 2/5 patients) inverse treatment plannings were re-optimized at many dose levels (from 64.8 to 108 Gy with 3.6 Gy intervals). In this case, three different values of alpha/beta (10, 3, 1.5)were used for TCP calculation. The 3DCRT plan consisted of a 3-fields technique; in the IMRT plans, five equi-spaced beams were applied. The Helios Inverse Planning software from Varian was used for both the 2D IMRT and the 1D IMRT inverse optimization, the last one being performed fixing only one available pair of leaves for modulation. A previously proposed forward 1D IMRT 'class solution' technique was also considered, keeping the same irradiation geometry of the inversely optimized IMRT techniques.
With the first method, the average gains in TCP(NTCP(rectum)=5%) of the 2D IMRT technique, with respect 3DCRT, were 10.3 and 7.8%, depending on the choice of the DVHs constraints during the inverse optimization procedure (set (a) and set (b), respectively). The average gain (DeltaTCP(NTCP(rectum)=5%)) coming from the inverse 1D IMRT optimization was 5.0%, when fixing the set (b) DVHs constraints. Concerning the forward 1D IMRT optimization, the average gain in TCP(NTCP(rectum)=5%) was 4.5%. The gain was found to be correlated with the degree of overlapping between rectum and PTV. When comparing 2D IMRT and 1D IMRT, in the case of the more realistic set (b) constraints, DeltaTCP(NTCP(rectum)=5%) was always less than 3%, excepting one patient with a very large overlap region. Basing our choice on this result, the second method was applied to this patient and one of the remaining. Through the inverse re-optimization of the treatment plans at each dose level, the gain in TCP(NTCP(rectum)=5%) of the inverse 2D technique was significantly higher than the ones obtained by applying the first method (concerning the two patients: +6.1% and +2.4%), while no significant benefit was found for inverse 1D. The impact of changing the alpha/beta ratio was less evident in the patient with the lower gain in TCP(NTCP(rectum)=5%).
The expected benefit due to IMRT with respect to 3DCRT seems to be relevant when the overlap between PTV and rectum is high. Moreover, the difference between the inverse 2D and the simpler inverse or forward 1D IMRT techniques resulted in being relatively modest, with the exception of one patient, having a very large overlap between rectum and PTV. Optimizing the inverse planning at each dose level to find TCP(NTCP(rectum)=5%)e level to find TCP(NTCP(rectum)=5%) can improve the performances of inverse 2D IMRT, against a significant increase of the time for planning. These results suggest the importance of selecting the patients that could have significant benefit from the application of IMRT.
调强放射治疗(IMRT)被认为是一种合适的技术,可在前列腺癌高剂量放疗时保护直肠壁,同时保持对计划靶区(PTV)的满意照射。然而,到目前为止,很少有研究试图评估其相对于传统三维(3D)适形放疗(CRT)的预期获益。
通过放射生物学模型评估在前列腺癌病例中,一维和二维IMRT相对于3DCRT的预期临床获益。为增强IMRT的效果,考虑了包含前列腺和精囊(P+SV)的凹形PTV情况。
选择了5例具有包含P+SV的凹形PTV的患者。在计划过程中应用了两组不同的约束条件:第一组中,接受PTV内剂量分布相当大的不均匀性(组(a));另一组(组(b))则要求更高的均匀性。分别通过Webb-Nahum模型和Lyman-Kutcher模型计算肿瘤控制概率(TCP)和正常组织控制概率(NTCP)指标。考虑64.8至100.8 Gy的剂量区间,使用两种不同方法找到直肠的NTCP为5%时的剂量值(D(NTCP(直肠)=5%)),并得出其他关键结构相应的TCP(NTCP(直肠)=5%)和NTCP(NTCP(直肠)=5%)。第一种方法中,计划的逆向优化仅在固定的75.6 Gy ICRU剂量下进行;第二种方法(应用于2/5的患者)在多个剂量水平(从64.8至108 Gy,间隔3.6 Gy)重新优化逆向治疗计划。在这种情况下,计算TCP时使用了三个不同的α/β值(10、3、1.5)。3DCRT计划采用三野技术;在IMRT计划中,应用五束等间距射束。瓦里安公司的Helios逆向计划软件用于二维IMRT和一维IMRT的逆向优化,一维IMRT的逆向优化仅固定一对可用叶片进行调制。还考虑了先前提出的正向一维IMRT“类解决方案”技术,保持与逆向优化的IMRT技术相同的照射几何形状。
第一种方法中,二维IMRT技术相对于3DCRT,在TCP(NTCP(直肠)=5%)方面的平均获益分别为10.3%和7.